ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2020 American Transplant Congress

    Waitlist-Conditioned Transplant Rate is Not an Appropriate Metric for Benchmarking Access to Kidney Transplantation

    D. Anderson, H. Qu, P. MacLennan, M. Mustian, R. Reed, A. C. Kale, B. Orandi, B. Shelton, V. Kumar, J. Locke, M. Hanaway

    University of Alabama at Birmingham, Birmingham, AL

    *Purpose: Transplant rate is used as a primary metric of center performance as reported by the SRTR. However, the calculation of transplant rate can be…
  • 2020 American Transplant Congress

    Molecular Diagnosis and Risk Prediction in BK Virus Nephropathy: Discovery and Multicenter Validation of Novel Intragraft Gene Expression Signatures

    B. Adam1, Z. Kikic2, Y. Bouatou3, J. Gueguen3, B. Robin3, G. Reid1, H. Regele2, M. Rabant3, A. Loupy3, M. Mengel1

    1University of Alberta, Edmonton, AB, Canada, 2Medical University of Vienna, Vienna, Austria, 3Paris Transplant Group, Paris, France

    *Purpose: Novel tools are needed to improve diagnosis and risk prediction in BK virus nephropathy (BKVN). This study aimed to assess the utility of intragraft…
  • 2020 American Transplant Congress

    Predictive Validity of Functional Status on Mortality in Adult Kidney Transplant Recipients

    N. Chu, Z. Shi, D. Segev, M. McAdams Demarco

    Johns Hopkins, Baltimore, MD

    *Purpose: Frailty and disabilities, though not routinely measured, are highly prevalent in kidney transplant (KT) recipients and predict poor post-transplant outcomes. The Karnofsky Performance Scale…
  • 2020 American Transplant Congress

    Effect of Glecaprevir/Pibrentasvir on Weight-Adjusted Tacrolimus Trough/Dose Ratios in Heart and Kidney Recipients

    D. Nnani1, A. Campbell1, M. Ajaimy2, S. R. Patel3, O. Saeed3, D. J. Goldstein4, J. Graham5, U. P. Jorde3

    1Pharmacy, Montefiore Medical Center, Bronx, NY, 2Medicine, Montefiore Medical Center, Bronx, NY, 3Division of Cardiology, Department of Medicine, Montefiore Medical Center, Bronx, NY, 4Cardiothoracic Surgery, Montefiore Medical Center, Bronx, NY, 5Surgery, Montefiore Medical Center, Bronx, NY

    *Purpose: An innovative strategy to meet the demands of patients requiring heart or kidney transplantation is the acceptance of hepatitis C viremic organs. Direct acting…
  • 2020 American Transplant Congress

    Epitope Analysis of Complement-Binding De Novo Donor-Specific HLA Class II Antibody

    K. Yamanaka, M. Hashimoto, T. Kinoshita, Y. Fujita, S. Matsumura, T. Imanaka, A. Taniguchi, T. Yoshida, H. Kishikawa

    Department of Kidney Transplantation Center, Hyogo Prefectural Nishinomiya Hospital, Nishinomiya, Hyogo, Japan

    *Purpose: Patients with de novo donor specific antibody (dnDSA) after kidney transplantation have a poorer prognosis than patients without dnDSA. Meanwhile, patients with dnDSA do…
  • 2020 American Transplant Congress

    Health Professional Level Barriers to Living Donor Kidney Transplantation: A Mixed Methods Study

    R. Iskander1, M. Cantarovich1, N. Dendukuri1, M. Fortin2, S. Sandal1

    1McGill University, Montreal, QC, Canada, 2University of Montreal, Montreal, QC, Canada

    *Purpose: Despite the benefits of living donor kidney transplantation (LDKT), rates have stagnated. Efforts to increase LDKT have focused on patient level barriers. Health professionals…
  • 2020 American Transplant Congress

    Incidence and Risk Factors of Post-Transplant Erythrocytosis in Deceased Donor Kidney Transplantation

    S. Alasfar, Y. Jia, I. E. Hall, H. Thiessen Philbrook, S. G. Mansour, M. D. Doshi, S. Mohan, J. S. Bromberg, P. P. Reese, C. Parikh

    DDS Consortium, Baltimore, MD

    *Purpose: Post-transplant erythroytosis (PTE) is clinically important condition after kidney transplantation (KTx). Previously published literature from single-center studies, demonstrated variable incidence rates between 8-15%. We…
  • 2020 American Transplant Congress

    Can a Patient with Von Willebrand Disease Donate a Kidney?

    Y. Marie1, W. McKane1, R. Maclean2, R. Pararajasingam1

    1Renal Transplantation, Sheffield Kidney Institute, Sheffield, United Kingdom, 2Haematology, Sheffield Teaching Hospitals, Sheffield, United Kingdom

    *Purpose: Von Willebrand disease (VWD) is a haematological condition that can be challenging to deal with during any operative intervention. We report a successful example…
  • 2020 American Transplant Congress

    Late Pneumocystis Jirovecii Pneumonia Often Misdiagnosed

    M. Samaniego1, R. Prashar1, N. Khoury2, A. Patel2

    1Transplant Institute, Henry Ford Health System, Detroit, MI, 2Transplant Institute, Henry Ford Health System, Ann Arbor, MI

    *Purpose: Since 2/2018, we have identified 60 transplant recipients presenting with late PCR confirmed Pneumocystis jirovecii (PJP). Of this initial group, 17 kidney transplant recipients…
  • 2020 American Transplant Congress

    Optimal Transition for Transplant Recipients: A Model of Care in an Integrated Health Care System

    S. Zheng1, L. Pravoverov1, A. Nazarova1, D. Adey2, N. B. Goes1

    1The Permanente Medical Group, San Francisco, CA, 2Kidney and Transplantation Program, University of California San Francisco, San Francisco, CA

    *Purpose: Transplantation is the treatment of choice for ESRD. While short-term outcomes have improved, long-term outcomes lag. Many factors may explain the long-term lag including…
  • « Previous Page
  • 1
  • …
  • 161
  • 162
  • 163
  • 164
  • 165
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences